Gene · 8174
Papers1,829
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,829
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting integrin pathways: mechanisms and advances in therapy. | Signal Transduct Target Ther | 2023 | 36588107 | PubTator, text mining | PubMed |
| Inflammation and cognition in severe mental illness: patterns of covariation and subgroups. | Mol Psychiatry | 2023 | 36577840 | PubTator, text mining | PubMed |
| Mucosal Addressin Cell Adhesion Molecule 1 Expression Reflects Mucosal Inflammation and Subsequent Relapse in Patients with Ulcerative Colitis. | J Crohns Colitis | 2023 | 36511086 | PubTator, text mining | PubMed |
| Pharmacokinetics and Safety of Vedolizumab Following Administration of a Single Intravenous Dose in Healthy Chinese Subjects. | Eur J Drug Metab Pharmacokinet | 2023 | 36400983 | PubTator, text mining | PubMed |
| Editing a gateway for cell therapy across the blood-brain barrier. | Brain | 2023 | 36397727 | PubTator, text mining | PubMed |
| Issues for patchy tissues: defining roles for gut-associated lymphoid tissue in neurodevelopment and disease. | J Neural Transm (Vienna) | 2023 | 36309872 | PubTator, text mining | PubMed |
| Expression and function of α4β7 integrin predict the success of vedolizumab treatment in inflammatory bowel disease. | Transl Res | 2023 | 36272713 | PubTator, text mining | PubMed |
| Autologous regulatory T-cell transfer in refractory ulcerative colitis with concomitant primary sclerosing cholangitis. | Gut | 2023 | 35428657 | PubTator, text mining | PubMed |
| Medicina de precisión en la enfermedad inflamatoria intestinal. | Acta Gastroenterol Latinoam | 2022 | 41341374 | PubTator, text mining | PubMed |
| ICAMs are dispensable for influenza clearance and anti-viral humoral and cellular immunity. | Front Immunol | 2022 | 36895258 | PubTator, text mining | PubMed |
| The emerging role of exosomes in innate immunity, diagnosis and therapy. | Front Immunol | 2022 | 36726968 | PubTator, text mining | PubMed |
| Tertiary lymphoid structures are critical for cancer prognosis and therapeutic response. | Front Immunol | 2022 | 36713409 | PubTator, text mining | PubMed |
| [Vedolizumab for treatment of steroid-refractory intestinal acute graft-versus-host disease: two cases report and literature review]. | Zhonghua Xue Ye Xue Za Zhi | 2022 | 36709113 | PubTator, text mining | PubMed |
| The role of Th17 cells in inflammatory bowel disease and the research progress. | Front Immunol | 2022 | 36700221 | PubTator, text mining | PubMed |
| Effects of the Antioxidant Quercetin in an Experimental Model of Ulcerative Colitis in Mice. | Medicina (Kaunas) | 2022 | 36676712 | PubTator, text mining | PubMed |
| Diffuse Metastatic Melanoma in the GI Lumen Following Immune Checkpoint Inhibitor Colitis Treatment. | Case Rep Gastroenterol | 2022 | 36636364 | PubTator, text mining | PubMed |
| Dendritic Cell-Triggered Immune Activation Goes along with Provision of (Leukemia-Specific) Integrin Beta 7-Expressing Immune Cells and Improved Antileukemic Processes. | Int J Mol Sci | 2022 | 36613907 | PubTator, text mining | PubMed |
| Analysis of immunologic comorbidities in ulcerative colitis patients: a tool to prevent exacerbations in ulcerative colitis cases. | Nagoya J Med Sci | 2022 | 36544593 | PubTator, text mining | PubMed |
| Fibroblastic reticular cells orchestrate long-term graft survival following recipient treatment with CD40 ligand-targeted costimulatory blockade. | J Clin Invest | 2022 | 36519546 | PubTator, text mining | PubMed |
| Role of intestinal flora in primary sclerosing cholangitis and its potential therapeutic value. | World J Gastroenterol | 2022 | 36504550 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8174/papers?page=14